BLAINTRATRACHEALSUSPENSION
Approved
Jul 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SURVANTA (beractant) by AbbVie is surfactant activity [moa]. First approved in 1991.
Drug data last refreshed 12h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SURVANTA (beractant) is a natural lung surfactant replacement therapy administered via intratracheal instillation as a suspension. It restores surfactant activity in the lungs by reducing surface tension, enabling improved gas exchange and respiratory function. The drug is indicated for respiratory distress syndrome in premature infants.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely focused on cost defense and niche positioning rather than growth initiatives.
Mechanism of Action
Surfactant Activity
Pharmacologic Class:
Surfactant
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
SURVANTA represents a legacy, late-lifecycle product where career opportunities focus on maximizing profitability, defending market share against generics, and managing regulatory compliance in a specialized neonatal indication. Professionals joining this team should expect defensive rather than growth-oriented strategies and strong focus on operational excellence and cost management.
Brand Manager
Worked on SURVANTA at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.